Related Experiment Video
Updated: Sep 24, 2025

11:32
Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
1.1K
Cathepsin B Relocalization in Late Membrane Disrupted Neurons Following Diffuse Brain Injury in Rats
Martina L Hernandez1, Michael Marone2, Karen M Gorse1
1Anatomy and Neurobiology, 6889Virginia Commonwealth University, Richmond, Virginia, USA.
ASN Neuro
|May 3, 2022
Summary
Weeks after traumatic brain injury (TBI), lysosomal Cathepsin B (Cath B) moves into the cytosol of neurons with damaged membranes. This relocalization, along with membrane disruption, is linked to neuronal atrophy, suggesting a late therapeutic target.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Traumatic brain injury (TBI) causes long-term damage, but mechanisms of neuronal membrane disruption are unclear.
- Lysosomal Cathepsin B (Cath B) redistribution to the cytosol is implicated in cell death.
- Chronic effects of Cath B and membrane disruption after diffuse TBI are poorly understood.
Purpose of the Study:
- To investigate Cathepsin B (Cath B) and neuronal membrane disruption chronically after diffuse TBI.
- To assess Cath B expression, activity, and localization in relation to neuronal damage and atrophy.
Main Methods:
- Adult male Sprague-Dawley rats underwent central fluid percussion injury (CFPI).
- Western blot analysis assessed Cath B, Bak, AIF, and Bcl-xl expression and Cath B activity.
- Immunohistochemistry, quantitative image analysis, and ultrastructural verification evaluated Cath B localization.
Main Results:
- No significant differences in Cath B expression or activity were observed between sham and injured rats at any time point.
- Immunohistology revealed Cath B sub-cellular relocalization to the cytosol in membrane-disrupted neurons at 2 and 4 weeks post-injury.
- Both membrane disruption and Cath B relocalization were associated with neuronal atrophy (smaller soma and nucleus size).
Conclusions:
- Cathepsin B (Cath B) relocalizes to the cytosol in neurons with disrupted membranes weeks after diffuse TBI.
- This late-stage relocalization and membrane disruption correlate with neuronal atrophy.
- These findings suggest a potential therapeutic window for treating chronic neuronal damage following TBI.

